Nikolova et al. found that the soluble syndecan-1 affects proliferation and invasiveness of breast cancer cells associated to a molecular signature including downregulation of TIMP-1, alteration in levels of uPAR, the Rho family of small guanosine triphosphatases and of integrins [41]. Here, TIMP1 is linked to breast carcinoma.